Bispecific VHH Production

• 

  Overcoming challenges in bispecific VHH production for immunotherapy

  Bi-specific VHHs as immuno-therapeutic agents, however, are not trivial to produce, also the Yaohai's product such as GMP Anti-HER3 VHH Production. At times, the cells that create antibodies grow weary and are unable to develop enough of these molecules. Or the antibodies fail to lock onto the cancer cells as Yaohai would like them to. This is the reason, Yaohai keep on searching for new and advance way to solve these issues to update the good medicine of those who are agonized from Cancer.

• 

  Novel approaches to bispecific VHH production for personalized medicine

  This is done by extracting and examining the blood of a patient for those perfect antibodies that will serve his body, along with the GMP Anti-MMRCD206 VHH manufactured by Yaohai. So, they engineer a bi-specific VHH made up of these specialized antibodies — specifically tailored for that individual. It allows for a personalized touch which means that we can better guarantee that the medicine will work for that particular person.

• 

  Advanced techniques in bispecific VHH production for improved cancer treatmen

  They have one more fewie, which is called "affinity maturation." This technique makes the bi-specific VHHs adhere to the cancer cells even more efficiently, same with Yaohai's VLP-based Vaccine Manufacturing. They are also leveraging several new concepts that can make the bbi-specificVHHs last longer in the body so they do not get cleared away by the immune system. This matters since the longer these antibodies are able to be active (by definition), the more powerful they will be at preventing disease.

Why choose Yaohai Bispecific VHH Production?

• Customization, Efficiency & Cost-Effectiveness

  Yaohai Bio-Pharma has experience in the manufacture of biologics derived from microorganisms. We offer tailored RD solutions and manufacturing while minimizing the risk. We have worked with diverse methods, such as Bispecific VHH Production of vaccines (including peptides), growth factors, hormones, and Cytokines. We specialized in multiple microbial hosts, including yeast extracellular and intracellular (yield up to 15 g/L) bacteria periplasmic secretion, soluble intracellular, and inclusion bodies (yield up to 10 grams/L). We also have a BSL-2 fermentation platform to create bacterial vaccines. We specialize in improving processes, increasing product yields, as well as reducing production costs. We have an efficient technology team that guarantees timely and quality project delivery. This allows us to deliver your exclusive products quicker to market.

• Quality System & Global Regulatory Compliance

  Yaohai BioPharma is a Top 10 Microbial CDMO that incorporates quality control and regulatory matters. We have a quality system which is in line with current GMP standards and international regulations. Our regulatory team is knowledgeable in global regulatory frameworks to accelerate biological launches. We ensure traceable manufacturing processes and top-quality products that are compliant with the requirements of the US FDA, EU EMA, Australia TGA, and Bispecific VHH Production. Yaohai BioPharma has successfully passed the audit on site of the European Union's qualified Person (QP) for our GMP quality system and production site. In addition, we've cleared the first certification audits of the ISO9001 Quality Management System, ISO14001 Environmental Management System, and ISO45001 Occupational Health and Safety Management System.

• Professional Expertise & Extensive Experience

  Bispecific VHH Production is a leading in microbial biologics CDMO. Our focus has been on microbial-produced vaccines and therapeutics that are suited for human, veterinary, as well as pet health management. We have the most cutting-edge RD platforms and manufacturing technology which cover the entire procedure beginning with the development of microbial strains and cell banking, to process and method development, to commercial and clinical production which ensures successful delivery of innovative solutions. Over time, we have accumulated vast knowledge of microbial-based bio processing. Over 200 projects have been successfully completed, and we assist our clients to comply with regulations like those of US FDA and EU EMA. We also help them to navigate Australia TGA and China NMPA. Our professional expertise and extensive experience allows us to quickly respond to market demands and provide bespoke CDMO services.

• Robust Supply Chain & Manufacturing Capabilities

  Yaohai Bio-Pharma, a top 10 producer of biological products, is a specialist in microbial fermentation. We have built an advanced facility that is equipped with advanced facilities as well as robust RD and manufacturing capabilities. Five drug substance production lines that are compliant with GMP standards for microbial purification and fermentation along with two automated fill and finishing lines for vials, cartridges and needles pre-filled are available. The scales for fermentation available are 100L, 500L, 1000L and 2000L. The filling volume ranges from 1ml to Bispecific VHH Production. Syringes or cartridges pre-filled are filled with the equivalent of 1-3ml. Our cGMP-compliant production workshop ensures steady supply of clinical samples and commercial products. The bulk molecules produced in our factory can be shipped worldwide.

Related product categories

• AAV Plasmid Manufacturing
• Analytical Methods for Plasmid DNA
• Bacteriophage AP205 VLP Manufacturing
• Bacteriophage Q VLP Manufacturing
• Chimeric VLP Vaccine Manufacturing
• Conjugate VLP Vaccines Manufacturing
• DNA Vaccine Manufacturing
• E. coli Fermentation for VLP Production
• GLP-1 Agonist Manufacturing
• GLP-1 Analog Manufacturing

Not finding what you're looking for?
Contact our consultants for more available products.